Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Opiant Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +6 vs. Q3 2022
- Shares held
- 2.13M
- +327.6K (+18.1%) vs. Q3 2022
- Total value
- $43.2M
- +$23.8M (+122.9%) vs. Q3 2022
- New holders
- 17
- 7 more added
- Sold out
- 11
- 11 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Western Standard LLC | 424,080 | $8.60M | 7.57% | +424,080 | New |
| Apis Capital Advisors, LLC | 214,000 | $4.34M | 5.03% | +10,000+4.9% | Added |
| Morgan Stanley | 197,652 | $4.01M | 0.00% | +190,441+2,641.0% | Added |
| Vanguard Group Inc | 190,773 | $3.87M | 0.00% | +3,615+1.9% | Added |
| Renaissance Technologies LLC | 146,415 | $2.97M | 0.00% | −30,500−17.2% | Reduced |
| Wells Fargo & Company | 136,814 | $2.77M | 0.00% | −68,303−33.3% | Reduced |
| Dimensional Fund Advisors LP | 100,209 | $2.03M | 0.00% | −12,283−10.9% | Reduced |
| New York Life Investment Management LLC | 61,912 | $1.26M | 0.01% | +61,912 | New |
| CSS LLC | 61,349 | $1.24M | 0.08% | +61,349 | New |
| Parkman Healthcare Partners LLC | 59,943 | $1.22M | 0.32% | −16,587−21.7% | Reduced |
| Ramius Advisors LLC | 55,298 | $1.12M | 1.08% | +55,298 | New |
| Yakira Capital Management, Inc. | 54,371 | $1.10M | 0.22% | +54,371 | New |
| Geode Capital Management, LLC | 48,591 | $985.0K | 0.00% | −136−0.3% | Reduced |
| Black Maple Capital Management LP | 48,548 | $984.6K | 1.58% | +48,548 | New |
| Ergoteles LLC | 43,200 | $876.1K | 0.03% | +43,200 | New |
| Schonfeld Strategic Advisors LLC | 42,300 | $857.8K | 0.01% | +42,300 | New |
| BlackRock Inc. | 39,425 | $799.5K | 0.00% | −497−1.2% | Reduced |
| Northern Trust Corp | 38,679 | $784.4K | 0.00% | −245−0.6% | Reduced |
| Gabelli Funds LLC | 37,119 | $752.8K | 0.01% | +37,119 | New |
| Gabelli & Co Investment Advisers, Inc. | 20,700 | $419.8K | 0.09% | +20,700 | New |
| Two Sigma Advisers, LP | 18,600 | $377.2K | 0.00% | −4,800−20.5% | Reduced |
| State Street Corp | 16,085 | $326.2K | 0.00% | +2,800+21.1% | Added |
| Fifth Lane Capital, LP | 15,000 | $304.2K | 0.44% | +15,000 | New |
| Citadel Advisors LLC | 14,169 | $287.3K | 0.00% | +14,169 | New |
| Harvest Management LLC | 12,000 | $243.4K | 0.28% | +12,000 | New |
| Mariner, LLC | 10,550 | $214.0K | 0.00% | −3,000−22.1% | Reduced |
| Gamco Investors, Inc. Et Al | 10,000 | $202.8K | 0.00% | +10,000 | New |
| Advisor Group Holdings, Inc. | 5,500 | $111.0K | 0.00% | −300−5.2% | Reduced |
| UBS Group AG | 2,802 | $56.8K | 0.00% | +1,356+93.8% | Added |
| Lindbrook Capital, LLC | 2,000 | $40.6K | 0.00% | +1,500+300.0% | Added |
| Royal Bank of Canada | 1,200 | $24.0K | 0.00% | −33−2.7% | Reduced |
| Bank of America Corp | 1,070 | $21.7K | 0.00% | +1,070 | New |
| Tower Research Capital LLC (TRC) | 744 | $15.0K | 0.00% | +310+71.4% | Added |
| Spire Wealth Management | 500 | $10.0K | 0.00% | 00.0% | Unchanged |
| Baldwin Brothers Inc | 300 | $6.08K | 0.00% | +300 | New |
| CoreCap Advisors, LLC | 266 | $5.39K | 0.00% | +266 | New |
| Federation des caisses Desjardins du Quebec | 180 | $3.65K | 0.00% | 00.0% | Unchanged |
| HealthInvest Partners AB | 0 | $0 | 0.00% | −210,000−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −152,278−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −126,978−100.0% | Sold out |
| Essex Investment Management Co LLC | 0 | $0 | 0.00% | −47,169−100.0% | Sold out |
| Perritt Capital Management Inc | 0 | $0 | 0.00% | −30,500−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,730−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −17,796−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −17,633−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,219−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −10,052−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| American Research & Management Co. | – | – | – | – | Not filed |